Structure - Activity relationship studies on benzofuran analogs of propafenone-type modulators of tumor cell multidrug resistance

Journal of Medicinal Chemistry

Volumn 39, Issue 24, 1996, Pages 4767-4774

  Ecker, Gerhard ^a   Chiba, Peter ^a   Hitzler, Manuela ^a   Schmid, Diethard ^a   Visser, Klaus ^b   Cordes, Hans Peter ^b   Csöllei, Josef ^a,c   Seydel, Joachim K ^b   Schaper, Klaus Jürgen ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b RESEARCH CENTER BORSTEL   (Germany)

^c UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOFURAN DERIVATIVE; PROPAFENONE;

ANIMAL CELL; ARTICLE; DRUG SYNTHESIS; LIPOPHILICITY; LYMPHATIC LEUKEMIA; MULTIDRUG RESISTANCE; NONHUMAN; STRUCTURE ACTIVITY RELATION;

BENZOFURANS; CALORIMETRY, DIFFERENTIAL SCANNING; CELLS, CULTURED; DAUNORUBICIN; DRUG RESISTANCE, MULTIPLE; ETHANOLAMINES; LIPOSOMES; MAGNETIC RESONANCE SPECTROSCOPY; MEMBRANES, ARTIFICIAL; P-GLYCOPROTEIN; PROPAFENONE; REGRESSION ANALYSIS; RHODAMINE 123; RHODAMINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030449507     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm960384x     Document Type: Article

References (37)

1. Fan, D.; Beltran, T. J.; O'Brien, C. A. Reversal of multidrug resistance. In Reversal of multidrug resistance in cancer; Kellen, J. A., Ed.; CRC Press: Boca Raton, FL, 1994.
2. Juliano, R. L.; Ling, V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta 1976, 455, 152-162.
3. Higgins, C. F.; Hiles, I. D.; Salmonel, G. P. C.; Gill, D. R.; Downie, J. A.; Evans, I. J.; Holland, I. B.; Gray, L.; Buckel, S. D.; Bell, A. W.; Hermodson, M. A. A family of related ATP-binding subunits coupled to many distinct biological processes in bacteria. Nature 1986, 323, 448-450.
4. Kellen, J. A. Multidrug Resistance. In Reversal of multidrug resistance in cancer; Kellen, J. A., Ed.; CRC Press: Boca Raton, FL, 1994; pp 1-19.
5. Li, X.-Z.; Ma, D.; Livermore, D. M.; Nikaido, H. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: Active efflux as a contributing factor to β-lactam resistance. Antimicrob. Agents Chemother. 1994, 38, 1742-1752.
6. Parkinson, T.; Falconer, D. J.; Hitchcock, C. A. Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata. Antimicrob. Agents Chemother. 1995, 39, 1696-1699.
7. Clark, F. S.; Parkinson, T.; Hitchcock, C. A.; Gow, N. A. R. Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: Possible role for drug efflux in drug resistance. Antimicrob. Agents Chemother. 1996, 40, 419-425.
8. Sanglard, D.; Kuchler, K.; Ischer, F.; Pagani, J.-L.; Monod, M.; Bille, J. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involves specific multidrug transporters. Antimicrob. Agents Chemother. 1995, 39, 2378-2386.
9. Gollapudi, S.; Reddy, M.; Gangadharam, P.; Tsuruo, T.; Gupta, S. Mycobacterium tuberculosis induces expression of P-glycoprotein in promonocytic U1 cells chronically infected with HIV type 1. Biochem. Biophys. Res. Commun. 1994, 199, 1181-1187.
10. Ford, J. M.; Hait, W. N. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev. 1990, 42, 155-199.
11. Tsuruo, T.; Iida, H.; Tsukagoshi, S.; Sakurai, Y. Overcoming of vincristine resistance in P 388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res. 1981, 41, 1967-1972.
12. Chauffert, B.; Martin, M.; Hamman, A.; Michel, M. F. Amiodaron-induced enhancement of doxorubicin and 4′-deoxydoxorubicin cytotoxicity to rat colon cancer cells in vitro and in vivo. Cancer Res. 1986, 46, 825-830.
13. Chiba, P.; Ecker, G.; Jäger, W.; Freudhofmayer, E.; Gekeler, V.; Fleischhacker, W. A new group of class I antiarrhythmic drug analogs reestablishes daunomycin sensitivity in multidrug-resistant T-lymphoblasts. Proc. Am. Assoc. Cancer Res. 1993, 34, 321.
14. Tsuruo, T.; Iida, H.; Tsukagoshi, S.; Sakurai, Y. Potentiation of vincristine and adriamycine in human hematopoietic tumor cell lines by calcium antagonists and calmodulin inhibitors. Cancer Res. 1983, 43, 2267-2272.
15. Ford, J. M.; Prozialeck, W. C.; Hait, W. N. Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance. Mol. Pharmacol. 1989, 35, 105-115.
16. Ford, J. M.; Bruggemann, E. P.; Pastan, I.; Gottesman, M. M.; Hait, W. N. Cellular and biochemical characterization of thioxanthenes for reversal of multidrug resistance in human and murine cell lines. Cancer Res. 1990, 50, 1748-1756.
17. Twentyman, P. R. Cyclosporins as drug resistance modifiers. Biochem. Pharmacol. 1992, 43, 109-117.
18. Atassi, G.; Pierre, A.; Kraus-Berthier, L.; Leonce, S.; Regnier, G.; Dhainaut, A. S 9788 corrects adriamycin and vincristine resistance on human and murine tumor cells in vitro and on P 388 leukemia in vivo. J. Cancer Res. Clin. Oncol. 1991, 117 (Suppl. 3), 108.
19. Hyafil, F.; Vergely, C.; Du Vignaud, P.; Grand Perret, T. In vitro and in vivo reversal of multidrug resistance by GF 120918, an acridonecarboxamide derivative. Cancer Res. 1993, 53, 4595-4602.
20. Raderer, M.; Scheithauer, W. Clinical trials of agents that reverse multidrug resistance. Cancer 1993, 72, 3553-3563.
21. Ecker, G.; Chiba, P. Structure-activity-relationship studies on modulators of the multidrug transporter P-glycoprotein - an overview. Wien. Klin. Wochenschr. 1995, 107, 681-686.
22. Pajeva, I. K.; Wiese, M.; Cordes, H.-P.; Seydel, J. K. Membrane interactions of some catamphiphilic drugs and relation to their multidrug-resistance-reversing ability. J. Cancer Res. Clin. Oncol. 1996, 122, 27-40.
23. Wadkins, R. M.; Houghton, P. J. The role of drug-lipid interactions in the biological activity of modulators of multidrug resistance. Biochim. Biophys. Acta 1993, 1153, 225-236.
24. Chiba, P.; Burghofer, S.; Richter, E.; Tell, B.; Moser, A.; Ecker, G. Synthesis, pharmacologic activity, and structure-activity relationships of a series of propafenone-related modulators of multidrug resistance. J. Med. Chem. 1995, 38, 2789-2793.
25. Chiba, P.; Ecker, G.; Schmid, D.; Drach, J.; Tell, B.; Goldenberg, S.; Gekeler, V. Structural requirements for activity of propafenone type modulators in PGP-mediated multidrug resistance. Mol. Pharmacol. 1996, 49, 1122-1130.
26. Nielek, S.; Lesiak, T. Chemistry of thiazole, I: Synthesis and properties of 2,3,5,6-tetrahydro-6-(3-methyl-benzofuran-2-yl)-imidazo[2,1-b]thiazole. Chem. Ber. 1982, 115, 1247-1251.
27. Ecker, G.; Mohr, E.; Geyer, R.; Fleischhacker, W. Enantioseparation of propafenone-type modulators of multidrug resistance on cyclodextrin based chiral stationary phases. Sci. Pharm. 1996, 64, 1-11.
28. Ecker, G.; Fleischhacker, W.; Noe, C. R. New benzofurane-type antiarrhythmic compounds related to propafenone. Heterocycles 1994, 38, 1247-1256.
29. Ecker, G.; Fleischhacker, W.; Helml, T.; Noe, C. R.; Scasny, S.; Lemmens-Gruber, R.; Studenik, C.; Marei, H.; Heistracher, P. Improved synthesis and pharmacologic activity of the enantiomers of a new benzofurane type antiarrhythmic compound. Chirality 1994, 6, 329-336.
30. Ecker, G.; Fleischhacker, W.; Helml, T.; Noe, C. R.; Studenik, C.; Schade, B.; Heistracher, P. Synthesis and pharmacodynamic activity of 2-(3-(2-phenylethyl)benzofuran-2-yl)-N-propyl-ethanamine. Arch. Pharm. 1995, 328, 343-348.
31. Lee, J. S.; Paull, K.; Alvarez, M.; Hose, C.; Monks, A.; Grever, M.; Fojo, A. T.; Bates, S. E. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen. Mol. Pharmacol. 1994, 46, 627-638.
32. Gekeler, V.; Frese, G.; Noller, A.; Handgretinger, R.; Wilisch, A.; Schmidt, H.; Muller, C.; Dopfer, R.; Klingbiel, T.; Diddens, H.; Probst, H.; Niethammer, D. Mdr1/P-glycoprotein, toposomerase and glutathione-S-transferase gene expression in primary and relapsed state adult and childhood leukemias. Br. J. Cancer 1992, 66, 507-517.
33. Ecker, G.; Chiba, P.; Schaper, K.-J. Estimation of chemosensitizing activity of modulators of multidrug resistance via combined simultaneous analysis of sigmoidal dose-response curves. J. Pharm. Pharmacol., submitted.
34. Ghose, A. K.; Pritchett, A.; Crippen, G. M. Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships III: modeling hydrophobic interactions. J. Comput. Chem. 1988, 9, 80-90.
35. P. Baricic and M. Mackov, distributed by Milan Hudecek, P. Horova 18, 841 07 Bratislava, Slowakia.
36. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63.
37. New, R. R. C., Ed. Liposomes: a practical approach; Oxford University Press: New York, 1990.